scholarly journals Impact of Graft-Versus-Host Disease on Lymphoma Progression after Allogeneic Stem Cell Transplantation: Retrospective Analysis from the Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

2021 ◽  
Vol 27 (3) ◽  
pp. S270
Author(s):  
Mizuki Watanabe ◽  
Junya Kanda ◽  
Takahiro Fukuda ◽  
Naoyuki Uchida ◽  
Kazuhiro Ikegame ◽  
...  
Keyword(s):  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Retrospective Analysis ◽  
Cell Transplantation ◽  
Graft Versus Host Disease ◽  
Allogeneic Stem Cell Transplantation ◽  
Working Group ◽  
Hematopoietic Cell Transplantation ◽  
Japan Society ◽  
Graft Versus Host

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Blood ◽  
2013 ◽  
Vol 121 (18) ◽  
pp. 3745-3758 ◽  
Author(s):  
Emily Blyth ◽  
Leighton Clancy ◽  
Renee Simms ◽  
Chun K. K. Ma ◽  
Jane Burgess ◽  
...  
Keyword(s):  
T Cells ◽  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Graft Versus Host Disease ◽  
Allogeneic Stem Cell Transplantation ◽  
Organ Damage ◽  
Host Disease ◽  
Graft Versus Host ◽  
Key Points

Key Points Infusion of CMV-specific T cells early posttransplant does not increase acute or chronic graft-versus-host disease. CMV-specific T cells early posttransplant reduce the need for pharmacotherapy without increased rates of CMV-related organ damage.

Sign in / Sign up

Export Citation Format

Share Document